נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 5 mg

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 10 mg

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 10 mg

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - nimodipin - infusjonsvæske, oppløsning - 0.2 mg/ ml

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - nimodipin - infusjonsvæske, oppløsning - 0.2 mg/ ml

האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - parkinsonsykdom - anti-parkinson medisiner - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - mesalazin - enterodepottablett - 1200 mg

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - mesalazin - enterodepottablett - 1200 mg

נורווגיה - נורבגית - Statens legemiddelverk

orifarm as - mesalazin - enterodepottablett - 1200 mg